Therapeutic Area
Dermatology CDMOs
Compare CDMOs with dermatology drug manufacturing expertise for topical formulations, transdermal systems, and injectable biologics for skin conditions. Filter by dosage form, scale, and certifications.
106 companies listed
About Dermatology Drug Manufacturing
Dermatology drug manufacturing is dominated by topical formulations -- creams, ointments, gels, lotions, foams, and solutions. These semi-solid dosage forms require specialized mixing equipment (high-shear mixers, homogenizers), precise temperature control during formulation, and validated filling lines for tubes, jars, pumps, and airless dispensers. The manufacturing expertise is distinct from solid dose or injectable production.
Skin penetration is the formulation challenge. The stratum corneum (outermost skin layer) is an effective barrier that most drugs cannot cross easily. CDMOs need formulation scientists experienced with penetration enhancers, nano-emulsions, liposomal delivery, and permeation testing (Franz diffusion cells). The choice of vehicle (cream vs ointment vs gel) significantly affects drug delivery and patient acceptance.
Biologics are entering dermatology. Monoclonal antibodies for psoriasis (anti-IL-17, anti-IL-23), atopic dermatitis (anti-IL-4R, anti-IL-13), and other inflammatory skin conditions have transformed treatment. While these are manufactured as standard injectable biologics, the combination with topical products in treatment protocols means some CDMOs serve both modalities for dermatology sponsors.
Companies (106)
BioInnovatise, Inc.
United States
BioInnovatise is a US-based CDMO specializing in quick-turnaround molecular biology services for early-stage drug discovery. Services include plasmid DNA services, viral vector packaging, and CRISPR-Cas9 services. The company collaborates with researchers in government, academia, and industry, focusing on custom cloning and the early discovery phase of drug development.
Viral VectorsAnalytical ServicesMethod Development
F
Ferndale Labs CDMO
United States
With more than 30 years of CDMO experience, Ferndale Labs CDMO supports pharmaceutical and healthcare companies developing and manufacturing liquid and semi-solid drug products. Our FDA-registered facility specializes in semi-solid and liquid formulations, including creams, gels, lotions, ointments, suspensions and solutions for Rx, OTC, and medical device applications. Built on agility, flexibility, and versatility, Ferndale helps partners advance programs from development through clinical supply and commercial manufacturing.
Frequently Asked Questions
What formulation capabilities are needed for topical drug manufacturing?+
CDMOs need: high-shear mixing and homogenization equipment, controlled temperature processing (many topicals require specific heating/cooling profiles), multiple filling formats (tubes, jars, pump bottles, airless dispensers), stability testing under dermatological conditions (photostability, temperature cycling), in vitro release testing (IVRT) and in vitro permeation testing (IVPT) using Franz diffusion cells, and rheology testing for viscosity specifications. Experience with both aqueous and non-aqueous vehicles is important.
How do generic topical drug requirements differ from oral generics?
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
